PAVM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PAVmed Inc (PAVM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is extremely poor, with significant YoY declines in revenue, net income, and EPS. Additionally, there are no positive trading trends, no recent news catalysts, and no strong technical or options data to support a bullish case. The absence of Intellectia Proprietary Trading Signals further diminishes the attractiveness of this stock.
The MACD is positive and contracting, indicating a weak bullish signal. RSI is neutral at 54.629, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are Pivot: 10.035, R1: 11.941, S1: 8.129, R2: 13.119, S2: 6.951. Overall, the technical indicators do not provide a strong buy signal.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Extremely poor financial performance in Q3 2025, with revenue down -99.50% YoY, net income down -109.84% YoY, and EPS down -120.38% YoY. No recent congress trading data or influential figure activity.
In Q3 2025, revenue dropped to $5,000 (-99.50% YoY), net income dropped to -$6,328,000 (-109.84% YoY), and EPS dropped to -8.81 (-120.38% YoY). Gross margin increased to -1000, but this is not a positive indicator given the overall financial decline.
No recent analyst ratings or price target changes available.
